Karmic Lifesciences participates in the BIO International Convention at Chicago

The 4-day BIO conference was held in Chicago at the McCormick Place Convention Center on May 3-6 2010. The event was a huge success attracting more than 15000 industry leaders from across 65 countries and offering an immense opportunity for learning, showcasing, networking and promotion. Karmic Lifesciences was represented by Dr.M.V Nagendran, President- Global Medical Affairs.

The Bio International Convention is undoubtedly one of the world’s largest annual events for the biotechnology industry and indeed offers a good platform to bring the different players of the Pharma/Biotech/CRO industry under one roof. Apart from presenting the end to end clinical research oriented services of Karmic Lifesciences through a value added presentation to a vast audience of 200, Dr.Nagendran shared his experience and role at Karmic during the panel discussions on Biosimilars and future of validation for Biosimilars as well as in the Asia Experience in Clinical Research.

Dr.MV Nagendran shares his BIO experience “In comparison to the previous years BIO experience, the conference this time was more successful and unique- direct evidence was the large participation of the India companies. The convention reflects participation of new entrants like South America and the former Russian states apart from the large number of innovations on display from Israel, Spain, France, Hungary etc. Karmic will definitely carry the interest forward and appear once again during its next show in 2011 at DC.”

Ms Nidhi Saxena, President and CEO of Karmic Lifesciences commented: “India undoubtedly offers a huge attraction to the drug developers across Pharma and Biotech players as a preferred location for their trial conduct. Participating in global conferences such as BIO is a relationship building exercise for Karmic Lifesciences and provides an excellent platform to reach out to the industry players with our differentiating qualities as a full fledged and Onco focused CRO.The leads generated and active dialogues held gives us good reason to participate once again next year.”

About Karmic Lifesciences: Karmic Lifesciences is a privately funded, ISO 9001:2000 certified and India’s fastest growing full-service CRO with end-to-end offerings in Clinical Trial Management, Clinical Data Management, Bio-Statistics, Medical Writing, Regulatory Submissions/Consulting and Pharmacovigilance. We have a track record of successfully supporting over 40 ICH-GCP compliant clinical studies across multiple therapeutic areas including Oncology, Neurology, Immunology, Cardiovascular, Endocrinology, Ophthalmology, Orthopedics, Respiratory etc. We have a state-of-the-art, 21 CFR part 11 compliant CDM infrastructure with ClinTrial 4.6, Inform EDC, SAS 9.1.3, MedDRA 13.0 and WHO-DD. Our team consists of 40 full-time professionals and 10+ KoLs and Senior Doctors as part of our Medical Advisory Board.